PFE: Things That Make You Go "Hmmm"

Mining Awareness +

Pfizer has Large R&D Facility in Wuhan China; Pfizer Employed Members of the Chinese Communist Party According to a Data Leak; Pfizer 3 Month Revenue from the Covid Vaccine was $3.5 Billion

22

Thursday

Jul 2021

Posted by miningawareness in Uncategorized≈ 1 Comment


Pfizer December 2020 SEC filing: archive.md/SMPQa



In 2010, Pfizer founded an R&D facility at China’s National Bio-industry Base in Wuhan (Biolake). By 2015, Pfizer was moving its “medicine safety business” from India to the Wuhan Biolake facility. Lan Zhanghua, the site head of Pfizer (Wuhan) Research & Development Co Ltd. stated in 2016: “Every one of Pfizer’s new drugs has indispensable contributions from the Wuhan team.“ He states that two R&D “functions run exclusively at Wuhan and nowhere else in the world… our Wuhan teams manage the clinical trial registry information and clinical trial master files for all Pfizer’s medicines”. archive.md/puanr Pfizer should be under investigation by the FBI-Homeland Security, but they almost certainly are not.



According to a data leak, Pfizer has employed 69 known members of the Chinese Communist Party. This sounds like a low number, considering that around 500 people work at their Wuhan site. Maybe this is members working for Pfizer outside China? See: “Huge Data Leak of 2 Million CCP Members Reveals ‘Golden Age’ of Chinese Espionage” By Daniel Y. Teng, December 14, 2020 archive.vn/5O49L



Pfizer is one of the major beneficiaries of SARS-CoV 2 (Covid-19), which started in Wuhan, China: “Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine: The company said its vaccine generated $3.5 billion in revenue in the first three months of this year”, New York Times, May 4, 2021: archive.md/l6Sy1. It accounted for almost a quarter of Pfizer’s total revenue and they will make close to an estimated $1 billion in vaccine profits for the first three months alone. (NYT estimate is $900 million pretax.)



“The Pfizer-BioNTech COVID-19 Vaccine is an unapproved vaccine that may prevent COVID-19. There is no FDA-approved vaccine” for Covid-19. Notice that they don’t put “death” as one of the risks. They merely note that “These may not be all the possible side effects of the Pfizer-BioNTech COVID-19 Vaccine. Serious and unexpected side effects may occur. Pfizer-BioNTech COVID-19 Vaccine is still being studied in clinical trials”. This is not informed consent! www.fda.gov/media/144414/download



As of December 2020, Pfizer’s SEC filing still listed the following subsidiaries in Communist China, which carries the false name of “People’s Republic of China”: Pfizer (China) Research and Development Co. Ltd, Pfizer (Wuhan) Research and Development Co. Ltd., and Pfizer Biologics (Hangzhou) Co. Ltd., as well as Pfizer International Trading (Shanghai) Limited, Pfizer Investment Co. Ltd., Pfizer Pharmaceutical (Wuxi) Co., Ltd., Pfizer Pharmaceuticals Science and Technology Co., Ltd., Pfizer Finance Share Service (Dalian) Co., Ltd. archive.md/SMPQa Funny thing that the Wuhan R&D isn’t listed as one of their R&D locations on the Pfizer web site. Even prior to the Covid-19 outbreak, it wasn’t listed: web.archive.org/web/20190321054103/https://www.pfizer.com/science/research-development/centers If you do a search for Wuhan on their web site, you don’t find it, as of this writing. If you type China in the search you find some relevant things.



On a separate Pfizer (China) site (last updated in 2011) one can find regarding Pfizer’s China Research and Development Center (Shanghai and Wuhan): “CRDC supports Pfizer’s global biological and chemical pharmaceutical R&D programs across our clinical development pipeline, and serves as an important hub of Pfizer global and Asia-Pacific R&D activities. As such, CRDC is an integral part of Pfizer’s global R&D site network, providing support across many R&D disciplines, including clinical drug development, medical, regulatory and safety.” See this and more here: archive.md/IQBZy



Pfizer founded an R&D facility in Wuhan (October 8, 2010) at China’s National Bio-industry Base in Wuhan (Biolake). It was the first Fortune 500 company to located at Wuhan’s Biolake facility. By 2015, Pfizer was moving its “medicine safety business” (whatever that means) from India to the Wuhan Biolake facility.



Lan Zhanghua site head of Pfizer (Wuhan) Research & Development Co Ltd. stated: “We developed beyond expectation. Now the Wuhan team has comprehensive coverage in Pfizer’s medicine development. Every one of Pfizer’s new drugs has indispensable contributions from the Wuhan team.“



Whereas, Pfizer’s Wuhan team started “performing only one function to 12 functions in the R&D system. Two functions run exclusively at Wuhan and nowhere else in the world: ‘No other but our Wuhan teams manage the clinical trial registry information and clinical trial master files for all Pfizer’s medicines. These are of utmost importance – making any mistake or losing documents could mean the medicine would never go to market,’ Lan said.”



As of 2016, Pfizer employed almost 500 people at the Wuhan site.



At least eight of thirteen Fortune 500 pharmaceutical companies were located there, as of 2016. These included France’s Sanofi, which signed a cooperation agreement with China National Pharmaceutical Group and Wuhan East Lake Hi-tech Development Zone (Nov 25, 2013). Sanofi’s stated plan was “to co-create a production base in Biolake International Vaccine Park, with the aim of offering innovative technology and high-quality biological products worldwide.” See: “Pfizer leads the way for pharma companies at Biolake” By Wang Huazhong and Zhou Lihua , China Daily USA, 2016-06-29 archive.is/puanr And, see: “Medicine safety business of Pfizer transferred to Wuhan” Source: hubei. gov. cn 04/30/2015 archive.md/SKyM5



US Pfizer, Germany’s Bayer, Fresenius Kabi, Thermo Fisher, Honeywell and DuPont Pioneer were all located at Biolake, Wuhan, as of 2013: “8 world top 500 biopharmaceutical companies located in Wuhan”

Source: hubei. gov. cn 11/18/2013 10:11:09 See: archive.md/w9QJd



Pfizer charged with bribery in China and elsewhere (2012) miningawareness.wordpress.com/2021/07/22/us-charged-pfizer-with-bribery-in-china-elsewhere-including-travel-to-australia-conference-in-exchange-for-doctors-promising-to-use-no-less-than-4200-injections-a-year/



In 2009, “Pfizer noted that its Wuhan operation will liaise with local research institutes and universities “utilising the rich resources of local talent and existing industry capabilities to develop research collaborations”. It stressed that Shanghai will remain “the operations hub of Pfizer’s R&D effort in China”. See: “Pfizer to build R&D facility in Wuhan, China” 25th November 2009 by Kevin Grogan Pharma Times: archive.md/0M2Gx



Dan Changchun, deputy-director of Wuhan East Lake High-Tech Development Zone explained: “The zone provides favorable policies and infrastructure to attract internationally leading companies to stay and one key reason is to learn from their culture from outside…. “For example, we built an office building for the use of giant pharmaceutical company Pfizer, who will probably not contribute any tax revenue during my tenure. But what Pfizer brought to us is its concept.” See: “Valley grows culture to lead innovation” Updated: 2016-06-15 By Wang Huazhong and Zhou Lihua(chinadaily. com. cn) archive.md/P8weS



“The Wuhan National Bio-industry Base, also known as the Biolake, is China’s second largest state-level biotech industrial base in view of overall strength, located in Wuhan East Lake High-tech Development Zone”. “Pfizer building in the Biolake” photo included. It’s located on the waterfront. See: “China Optics Valley, Biolake, Wuhan East Lake High-tech Development Zone”: archive.md/VYUZF



BioProcess International Spotlight by BPI Staff Wednesday, December 16, 2015 featured JHL Biotech’s Wuhan facility. Excerpts: “The world’s largest biomanufacturing plant based on single-use technology has been constructed for JHL Biotech at the Biolake science park in Wuhan, China…. The Biolake site is designed to accommodate increasing local demand for biosimilars and innovative biopharmaceuticals…. CEO Racho Jordanov says, ‘Industry-wide, there is a clear focus on cost of goods and how this directly impacts final pricing.” archive.md/IzAUE



In 2021 Racho Jordanov was indicted for theft of trade secrets and fraud: miningawareness.wordpress.com/2021/07/22/former-ceo-and-coo-of-taiwan-headquartered-jhl-biotech-with-offices-in-wuhan-china-and-california-charged-with-conspiracy-to-steal-trade-secrets-and-commit-wire-fraud-exceeding-101-million/



Also featured in the same December 16, 2015 BPI article was “US Biodefense Study Emboldens Biotech”: “In late October, the Blue Ribbon Study Panel on Biodefense in the United States released its final report (www.biodefensestudy.org) recommending new approaches to developing medical countermeasures more quickly for emerging infectious disease threats…. The report calls out the crucial role of drug and vaccine medical countermeasures and the need for significant government funding…” archive.md/IzAUE



A current Pfizer job ad for Wuhan. In the best of all worlds, an FBI agent would apply to work there, since Pfizer is an American headquartered company. It might be risky for a journalist. The Wuhan East Lake area looks lovely, but its apparent perfection apparently comes at a high cost:


“WRDC in Wuhan R&D Center, China

•\Carry out case processing activities

•\Review, rank, verify, process and document case-related information: event terms; validity, seriousness, special scenarios; timelines; accuracy and consistency. Process cases based on these assessments

•\Review case criteria to determine the appropriate workflow for case processing

•\Assess cases to distinguish those with particular complexities and/or specific issues, and escalate appropriately

•\Write and edit the case narrative

•\Determine and perform appropriate case follow-up, including generation of follow-up requests

•\Review processed cases to verify accuracy, consistency, and compliance with process requirements, and review case data for special scenarios

•\Liaise with key partners, locally , and other stakeholders regarding safety data collection and data reconciliation

•\Develop and maintain expertise and knowledge for applicable corporate and global regulations, for guidelines, Standard Operating Procedures, for data entry conventions, and for search functions in the safety database

•\Determine reportability of scheduled reports , ensuring adherence to regulatory requirements

•\Consistently apply regulatory requirements and Pfizer policies

•\Participate, as appropriate, in local, internal and external safety activities

•\Experience in pharmacovigilance and/or data management preferred but not required

•\Experience and skill with medical writing an advantage

•\Demonstrated computer literacy

•\Experience in use and management of relational databases preferred

•\Health Care Professional or equivalent experience preferred

•\Ability, with supervision, to solve routine problems and to surface issues constructively

•\Ability to make basic decisions with an understanding of the consequences

•\Ability to achieve personal objectives while meeting departmental standards of performance

•\Ability to work under supervision in a matrix organization

•\Fluency in spoken and written English

* Carry out case processing activities

* Review, rank, verify, process and document case-related information: event terms; validity, seriousness, special scenarios; timelines; accuracy and consistency. Process cases based on these assessments

* Review case criteria to determine the appropriate workflow for case processing

* Assess cases to distinguish those with particular complexities and/or specific issues, and escalate appropriately

* Write and edit the case narrative

* Determine and perform appropriate case follow-up, including generation of follow-up requests

* Review processed cases to verify accuracy, consistency, and compliance with process requirements, and review case data for special scenarios

* Liaise with key partners, locally , and other stakeholders regarding safety data collection and data reconciliation

* Develop and maintain expertise and knowledge for applicable corporate and global regulations, for guidelines, Standard Operating Procedures, for data entry conventions, and for search functions in the safety database

* Determine reportability of scheduled reports , ensuring adherence to regulatory requirements

* Consistently apply regulatory requirements and Pfizer policies

* Participate, as appropriate, in local, internal and external safety activities

N: Not Applicable – 不适用 (China)

Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.” archive.md/zXoHu